Merck to Acquire Prometheus Biosciences for $10.8B

Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday.

Related Keywords

United States ,San Diego ,California ,Scott Glenn ,Stephan Targan ,Robertm Davis ,Mark Mckenna ,Janine Bilsborough ,Michaelj Yee ,Dermotp Mcgovern ,Jim Laur ,Health Science ,European Medicines Agency ,Pfizer ,Mayo Collaborative Services ,Sinai Medical Center ,Us Supreme Court ,Sinai Technology Transfer Office ,Colitis Organisation ,Merck Co ,Arena Pharmaceuticals ,Prometheus Biosciences ,European Crohn ,Cedars Sinai Medical Center ,Takeda Pharmaceutical ,Nimbus Therapeutics ,Human Papillomavirus ,Human Papillomavirus Quadrivalent ,Technology Transfer Office ,Prometheus Laboratories ,Federal Circuit ,Hart Scott Rodino Antitrust Improvements ,Prometheus Bioscience ,